Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein (2022)
- Authors:
- Castro, Julia T.
- Azevedo, Patrick
- Fumagalli, Marcílio Jorge
- Hojo-Souza, Natalia S.
- Salazar, Natalia
- Almeida, Gregório G.
- Oliveira, Livia I.
- Faustino, Lídia
- Antonelli, Lis R.
- Marçal, Tomas G.
- Augusto, Marconi
- Valiate, Bruno
- Fiorini, Alex
- Rattis, Bruna Amanda da Cruz
- Ramos, Simone Gusmão
- Piccin, Mariela Pires Cabral
- Nonato, Osvaldo Campos dos Santos
- Benevides, Luciana
- Magalhães, Rubens
- Cassaro, Bruno
- Burle, Gabriela
- Doro, Daniel
- Kalil, Jorge
- Durigon, Edison Luiz
- Salazar, Andrés
- Caballero, Otávia
- Santiago, Helton
- Machado, Alexandre
- Silva, João Santana da
- Fonseca, Flávio da
- Fernandes, Ana Paula
- Teixeira, Santuza R.
- Gazzinelli, Ricardo Tostes
- USP affiliated authors: SILVA, JOÃO SANTANA DA - FMRP ; RAMOS, SIMONE GUSMÃO - FMRP ; BENEVIDES, LUCIANA - FMRP ; DURIGON, EDISON LUIZ - ICB ; GAZZINELLI, RICARDO TOSTES - FMRP ; CASTRO, JÚLIA TEIXEIRA DE - FMRP ; FUMAGALLI, MARCILIO JORGE - FMRP ; RATTIS, BRUNA AMANDA DA CRUZ - FMRP ; PICCIN, MARIELA PIRES CABRAL - FMRP ; NONATO, OSVALDO CAMPOS DOS SANTOS - FMRP
- Unidades: FMRP; ICB
- DOI: 10.1038/s41467-022-32547-y
- Subjects: ANTICORPOS; LINFÓCITOS T; VACINAS; COVID-19; GLICOPROTEÍNAS; CORONAVIRUS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Nature Communications
- ISSN: 2041-1723
- Volume/Número/Paginação/Ano: v. 13, n. 1, art. 4831, p. 1-16, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CASTRO, Julia T. et al. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein. Nature Communications, v. 13, n. 1, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41467-022-32547-y. Acesso em: 10 fev. 2026. -
APA
Castro, J. T., Azevedo, P., Fumagalli, M. J., Hojo-Souza, N. S., Salazar, N., Almeida, G. G., et al. (2022). Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein. Nature Communications, 13( 1), 1-16. doi:10.1038/s41467-022-32547-y -
NLM
Castro JT, Azevedo P, Fumagalli MJ, Hojo-Souza NS, Salazar N, Almeida GG, Oliveira LI, Faustino L, Antonelli LR, Marçal TG, Augusto M, Valiate B, Fiorini A, Rattis BA da C, Ramos SG, Piccin MPC, Nonato OC dos S, Benevides L, Magalhães R, Cassaro B, Burle G, Doro D, Kalil J, Durigon EL, Salazar A, Caballero O, Santiago H, Machado A, Silva JS da, Fonseca F da, Fernandes AP, Teixeira SR, Gazzinelli RT. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein [Internet]. Nature Communications. 2022 ; 13( 1): 1-16.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1038/s41467-022-32547-y -
Vancouver
Castro JT, Azevedo P, Fumagalli MJ, Hojo-Souza NS, Salazar N, Almeida GG, Oliveira LI, Faustino L, Antonelli LR, Marçal TG, Augusto M, Valiate B, Fiorini A, Rattis BA da C, Ramos SG, Piccin MPC, Nonato OC dos S, Benevides L, Magalhães R, Cassaro B, Burle G, Doro D, Kalil J, Durigon EL, Salazar A, Caballero O, Santiago H, Machado A, Silva JS da, Fonseca F da, Fernandes AP, Teixeira SR, Gazzinelli RT. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein [Internet]. Nature Communications. 2022 ; 13( 1): 1-16.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1038/s41467-022-32547-y - Neutralizing antibody-independent immunity to SARS-CoV-2 in hamsters and hACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion protein
- Curcumin as a Potential Treatment for COVID-19
- ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients
- Desenvolvimento de proteína quimérica e avaliação de seu potencial vacinal contra COVID-19
- SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern
- Association of IL-9, IL-10, and IL-17 cytokines with hepatic fibrosis in human Schistosoma mansoni infection
- Blimp-1 signaling pathways in T lymphocytes is essential to control the Trypanosoma cruzi infection-induced inflammation
- Protective immunity against Gamma and Zeta variants after inactivated SARS-CoV-2 virus immunization
- Efeito da curcumina na expressão dos componentes da via mTOR no coração de camundongos submetidos a sepse experimental
- Linfócitos T produtores de IL-17 e células T reguladoras em tumor de mama invasivo
Informações sobre o DOI: 10.1038/s41467-022-32547-y (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003137514.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
